"(診療科目)内科一般、糖尿病、腎不全、透析、高血圧 内科一般、糖尿病、高血圧から末期腎不全の透析に至った患者さんまでを一貫して診療いたします。 また、透析につきましては夜間透析も行っています。"

During the past decade, Ohishi Naika Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ohishi Naika Clinic" are "End-stage Renal Disease" (1 trials), "Hemodiafiltration" (1 trials), "Hemodialysis" (1 trials), "Prevention of Thromboembolic Events" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Ohishi Naika Clinic" in a lesser frequency.

Most popular intervention types in "Ohishi Naika Clinic" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "BAY1213790 (Osocimab)" (1 trials), "Oral antihyperglycemic medication (OAM)" (1 trials), "Placebo" (1 trials) and "Tirzepatide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ohishi Naika Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ohishi Naika Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ohishi Naika Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ohishi Naika Clinic, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".